Home » Newsletters » BioWorld Asia

BioWorld Asia

April 5, 2000

View Archived Issues

MediGene, Schering Align In $52M Deal For HPV Vaccine

Researchers Identify Peptide That Triggers Celiac Disease

Celltech Buys U.S.-Based Cistron, Gains Access To IL-1 Technology

November AG Taking Program Public On Market In Germany

SR Pharma Sees Additional Positive Data From SRL172

Mologen Starts Phase II/III Cancer Gene Therapy Trial

Israeli Researchers Show Toxic Shock Antidote Works In Mice

Australian Stocks Doing Well, But Lag Behind U.S. Counterparts

Peptide Therapeutics In Talks With Potential Company Buyer

Transghne Obtains U.S. Patent Covering Adenovirus Technique

DevCo Licenses Lexipafant, Marking Third Deal In A Month

Cambridge Antibody Raises #90M In Scaled-Back Offering

Teva To Market Bio-Tropin As Part Of $20M BTG Deal

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.